The deal births a healthcare organisation with a market capitalisation expected to exceed $600m
Baker McKenzie has assisted CH2 Holdings Pty Limited (CH2) on its merger with Paragon Care Limited (Paragon Care).
Through the merger, a healthcare wholesaler, distributor, and manufacturer will be established, operating in the healthcare markets of Australia, New Zealand, and Asia. The market capitalisation of this organisation is estimated to exceed $600m.
“This strategic merger is expected to capitalise on and strengthen the combined operational capabilities of the two businesses in these rapidly growing markets”, said co-lead lawyers Steven Glanz and Lizzie Lu.
Glanz and Lu were joined by Louise Hang in working on the transaction, which was completed on 3 June.
CH2 is an Australian integrated distributor and wholesaler of pharmaceuticals, medical consumables, nutritional products, over-the-counter items, medical equipment, and medical supplies. Paragon Care, also based in Australia, supplies durable medical equipment, medical devices and consumable medical products. Paragon also provides maintenance services in relation to technical medical equipment for the health, aged care, and veterinary markets.
